Best Grants for Rare Diseases in New Hampshire

The FY26 Defense Established Program to Stimulate Competitive Research (DEPSCoR) aims to enhance research capabilities in eligible states by increasing the number of university researchers and institutions conducting relevant science and engineering research. Sponsored by the Department of Defense, this program will fund multiyear awards to promote research aligned with national security needs. Applications require a multi-stage submission process, emphasizing early registration and timely proposal submissions.

Researchers conducting respiratory care and airway management studies in New Hampshire and across the U.S. can receive support for original university hospital research. Grants from American Respiratory Care Foundation help respiratory diseases and systems investigators attend the AARC Congress with airfare, lodging, registration, and recognition for high-quality accepted abstracts.

Graduate students and other qualified investigators conducting respiratory care education or credentialing research can apply for up to US $5,000 in support, plus conference travel benefits. Grants from American Respiratory Care Foundation help New Hampshire respiratory health projects and rare disease–related studies that fit its respiratory diseases and systems focus advance their work.

Nonprofit organizations conducting respiratory care research, including work relevant to rare respiratory diseases in New Hampshire, can apply for the American Respiratory Care Foundation’s Parker B. Francis Respiratory Research Grant. Awards up to US $10,000 support projects where respiratory therapists or technicians are meaningfully involved, with physicians or respiratory care practitioners serving as principal investigators.

Focused on respiratory care research, the American Respiratory Care Foundation invites New Hampshire nonprofit organizations to apply for support of projects in respiratory care and cardiopulmonary medicine. Eligible projects must meaningfully involve respiratory therapists or technicians as investigators and may receive up to US $10,000 to supplement other research funding, including work related to rare respiratory diseases.

Early-career respiratory care researchers focusing on pediatric respiratory therapy can receive up to US $5,000 to support their first research projects and professional development. Grants from American Respiratory Care Foundation help New Hampshire and other U.S. investigators fund mentoring, hands-on research experience, and small equipment or supplies for respiratory diseases and systems studies.

Health care professionals working in respiratory diseases and systems in New Hampshire and worldwide can apply for an international fellowship that funds a structured, up-to-20-day observational visit in the U.S. The American Respiratory Care Foundation covers domestic lodging, food allowance, local transportation, and AARC Congress registration for fellows committed to advancing respiratory care.

Biomedical, behavioral, and clinical science faculty pursuing mentored research on cardiovascular, pulmonary, hematologic diseases, or sleep disorders in New Hampshire can access funding through the National Institutes of Health. This K01 award supports career development toward research independence, with up to US $130,000 available for mentored projects, including those relevant to respiratory and rare disease populations.

Early-stage pulmonary fibrosis researchers, including post-docs and junior faculty in fields like respiratory diseases, can apply for Pulmonary Fibrosis Foundation’s PFF Scholars awards of US $100,000 to support mentored research and career development. Eligible investigators in New Hampshire may benefit if they meet degree, appointment, and independence criteria.

Biomedical researchers and clinician-scientists conducting NHLBI-related clinical trials can access career transition funding that supports intramural and extramural research phases, including work relevant to respiratory diseases in New Hampshire. US Dept. of Health & Human Services: National Institutes of Health supports postdoctoral fellows moving from NHLBI intramural positions to independent roles at eligible U.S. institutions.

Research institutions and biomedical organizations working on leprosy can apply for The New York Community Trust’s Heiser Program, with awards from US $87,500 - US $250,000. Projects may include diagnosis, treatment, transmission blocking, or surveillance research, and New Hampshire rare disease researchers studying leprosy-related dermatological or neurological impacts may be eligible.

Early-career clinical or scientific investigators conducting innovative sarcoidosis research at U.S. institutions can receive fellowship support to build skills and advance patient care. With a mission to advance sarcoidosis research, Foundation for Sarcoidosis Research provides international applicants with US $150,000 over two years for fellow compensation and mentored career development.

Early-career research scientists at academic or research institutions in eligible low- and middle-income countries can apply for National Institutes of Health Emerging Global Leader Award support to conduct mentored clinical research. Grants from NIH help investigators working on cancer, respiratory, neurological, mental health, or related diseases, including rare respiratory conditions, which may benefit New Hampshire-focused collaborators.

Early-career research scientists at academic or research institutions in eligible low- or middle-income countries can apply for the Emerging Global Leader Award to support mentored health-related research and career development. Offered by the National Institutes of Health, this award provides approximately US $140,000 and may benefit investigators studying respiratory or other rare disease-related conditions, including work connected to New Hampshire partners.

With a mission to advance nonmalignant hematology research, the National Institutes of Health provides New Hampshire medical and research institutions with R01 funding for basic and early translational studies. Projects may address hematological systems alongside related areas such as aging, cardiovascular, kidney, endocrine, respiratory, digestive, diabetes, and sleep disorders, which may benefit some rare disease programs.

Small biomedical businesses developing technologies for rare heart, lung, blood, or sleep disorders that serve New Hampshire and other U.S. locations can seek up to US $3,500,000 for later-stage R&D and commercialization. With a mission to advance public health, NIH provides Phase IIB SBIR support to projects needing federal regulatory approval and third-party investment partnerships.

Small business concerns developing heart, lung, blood, or sleep disorder technologies that need federal regulatory approval can seek later-stage SBIR Phase IIB funding, including in New Hampshire. Grants from US Dept. of Health & Human Services: National Institutes of Health support commercialization milestones with up to US $3,500,000 for projects previously funded through SBIR or STTR Phase II awards.

Doctoral students conducting physical therapy research, including work on respiratory diseases and systems, can receive up to US $7,500 to support their coursework phase at accredited institutions; funding is available nationally, including New Hampshire. The Foundation for Physical Therapy Research prioritizes acute care, cardiology and pulmonary, PT education, and pelvic health topics.

The EMF/Fisher and Paykel High Flow Therapy Research aims to explore the use of high flow therapy as a first-line respiratory support in emergency departments. This research seeks to assess the number of patients with acute respiratory failure who may benefit from this therapy, understand the characteristics of EMS services, and identify patient outcomes. By analyzing these factors, the study intends to enhance patient care and inform effective health policies in emergency medicine.

The Hope APFED/AAAAI Grant Award aims to support innovative research projects related to Eosinophilic Disorders, excluding asthma, rhinitis, and eczema. This initiative encourages collaboration between the American Academy of Allergy, Asthma & Immunology and the American Partnership for Eosinophilic Disorders, providing a platform for independent researchers to secure future funding. Applicants must be AAAAI members and hold relevant academic positions, ensuring a commitment to advancing knowledge in allergy and immunology.

The NHLBI Catalyze program aims to transition basic science discoveries into effective treatments for diseases under the NHLBI mission. This initiative supports early-stage product definition, prototype design, and assay development for HLBS disorders. The R61 phase focuses on initial designs and experimental setups, while the R33 phase extends support for prototype testing and user feedback. Successful completion prepares products for in vivo testing, enhancing health and societal outcomes with NIH and other support.

The IRSS RIFM Special Award for Inhalation Toxicology offers a $500 prize for trainees contributing to inhalation toxicology research. Sponsored by the Society of Toxicology, this award encourages innovative evaluations of inhaled toxicants, exposure science advancements, and risk assessment research. Applicants must submit a one-page summary of their work and a pending abstract for presentation at the SOT Annual Meeting, alongside a mentor's support letter. This award aims to promote excellence in the field.

The Community Foundation of Shelby County

Our Mission

To inspire donor generosity and transform it into meaningful, lasting impact through charitable gifts.

Our Vision

To be the primary partner for donors who want to advance the community’s quality of life and capacity for excellence.

Heidi Norris Scholarship

Auglaize, Shelby or Mercer County residents majoring in Respiratory Therapy or a closely related field who are one year removed from high school, surpassed college freshman status and, have maintained a college GPA of not less than 2.5, and who are pursuing an Associate’s, Bachelor’s, or Master’s degree.

Selection based upon:

Financial need, academic ability, community and school service, and recommendations.

Awards

• One $1,500 scholarship

The Patient-Centered Outcomes Research Institute (PCORI) intends to release an Implementation of Findings From PCORI's Research Investments PCORI Funding Announcement (PFA) on Aug. 4, 2026, seeking to fund implementation projects that promote the uptake of peer-reviewed findings from specific PCORI-funded patient-centered comparative clinical effectiveness research (CER) in the context of the body of related evidence. This PFA is an open competition opportunity for principal investigators to propose implementation projects that move evidence toward practical use in improving health care and health outcomes. Applicants may propose projects with budgets up to $1.8 million in total direct costs.

PCORI seeks to fund implementation projects that incorporate active, multicomponent strategies that will lead to uptake and integration of evidence generated by PCORI-funded research in practice settings. Implementation should target specific end users with a clear interest in — and ability to benefit from — the evidence. Proposed implementation projects will adapt findings as needed to facilitate uptake in the proposed settings and accomplish scale-up to reach larger numbers and/or scale-out to reach broader populations and settings. Applicants must demonstrate commitment and buy-in — including from leadership as well as frontline staff critical to the success of the project — from proposed implementation sites across multiple health systems, such that they provide a supportive context and infrastructure for undertaking the proposed project. In addition, projects should involve regional and national stakeholder organizations positioned to extend uptake in broader venues.  

Applications must be guided by an established conceptual model or framework and, where possible, by evidence regarding effective strategies for implementing evidence-based practices and interventions. Additionally, applications must include a rigorous evaluation plan that documents the successful execution of the implementation approach and the impact of the project on health care and health outcomes as feasible and appropriate within the project scope.

The Childhood Asthma in Urban Settings Clinical Research Network (CAUSE) aims to enhance asthma prevention and treatment in economically disadvantaged pediatric populations. Funded by the NIH, CAUSE supports multi-site clinical studies to identify innovative strategies and treatment targets for asthma. Utilizing systems biology, the network seeks to discover specific disease endotypes suitable for new therapeutic approaches, addressing the high burden of asthma in urban settings.

The Asthma and Allergic Diseases Cooperative Research Centers (AADCRC) program, supported by the National Institute of Allergy and Infectious Diseases (NIAID), aims to enhance research on asthma and related allergic diseases. This initiative fosters multi-center, multidisciplinary research to explore disease mechanisms and treatment responses. By promoting clinical trials and observational studies, the AADCRC seeks to advance understanding and improve interventions for conditions such as asthma and food allergies, ultimately benefiting public health.

The US Flu Vaccine Effectiveness (VE) Network aims to enhance the effectiveness of vaccines against influenza and other respiratory pathogens, which are significant contributors to morbidity and mortality. This funding opportunity invites proposals for surveillance studies, including annual VE assessments, acute respiratory illness tracking, household transmission research, and immunogenicity studies. Applicants can apply for either Component A or B, with the option to include additional components based on their primary selection.